For instance, gemcitabine was shown to dramatically and significantly reduce myeloid-derived suppressor cells (MDSCs) in the spleens of tumor-bearing mice while increasing the anti-tumor potential of CD8+ T cells and activated natural killer cells (22). Here, CD8A is linked to neoplasm.